Legal & General Group Plc - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 63 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$2,283,100
-10.3%
256,528
+2.1%
0.00%0.0%
Q1 2024$2,545,557
+3.5%
251,289
+2.7%
0.00%0.0%
Q4 2023$2,460,344
+7.8%
244,567
+0.4%
0.00%0.0%
Q3 2023$2,283,142
-59.2%
243,665
+6.9%
0.00%
-50.0%
Q2 2023$5,592,422
+8.2%
227,983
+2.6%
0.00%0.0%
Q1 2023$5,170,641
-8.1%
222,202
-0.1%
0.00%0.0%
Q4 2022$5,627,400
+33.6%
222,339
+1.8%
0.00%0.0%
Q3 2022$4,212,000
-22.8%
218,438
+2.0%
0.00%0.0%
Q2 2022$5,457,000
+283.8%
214,257
+287.6%
0.00%
Q1 2022$1,422,000
-38.2%
55,275
+0.6%
0.00%
-100.0%
Q4 2021$2,301,000
-2.0%
54,960
+1.9%
0.00%0.0%
Q3 2021$2,347,000
+11.1%
53,934
+20.7%
0.00%0.0%
Q2 2021$2,113,000
+45.7%
44,680
+57.8%
0.00%0.0%
Q1 2021$1,450,000
+49.9%
28,309
-21.7%
0.00%
Q4 2020$967,000
+3.2%
36,160
+32.5%
0.00%
Q3 2020$937,000
-19.5%
27,285
-4.1%
0.00%
-100.0%
Q2 2020$1,164,000
+2884.6%
28,445
+2419.5%
0.00%
Q1 2020$39,000
+105.3%
1,129
-23.8%
0.00%
Q4 2019$19,0001,4820.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders